<SEC-DOCUMENT>0001213900-21-025274-index.html : 20210510
<SEC-HEADER>0001213900-21-025274.hdr.sgml : 20210510
<ACCEPTANCE-DATETIME>20210510075508
ACCESSION NUMBER:		0001213900-21-025274
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210510
DATE AS OF CHANGE:		20210510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GX Acquisition Corp.
		CENTRAL INDEX KEY:			0001752828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831702591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38914
		FILM NUMBER:		21905280

	BUSINESS ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2126163700

	MAIL ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ea140562-8k_gxacquisition.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea140562-8k_gxacquisition.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea140562ex99-1_gxacquisition.htm
<DESCRIPTION>PRESS RELEASE ISSUED MAY 10, 2021
<TEXT>
Document 2 - file: ea140562ex99-1_gxacquisition.htm

</DOCUMENT>
</SEC-DOCUMENT>